ADC Therapeutics SA (ADCT) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Adc Therapeutics Sa.

Watch the replay

Replay transcript excerpt

WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a0410c-e692-7fd2-b899-9fb86922b330 Created: 2026-08-27T02:29:21.371Z Duration: 1555.0432 Channels: 1 00:00:00.719 -- 00:00:03.280 Good morning, ladies and gentlemen, and welcome to 00:00:03.280 -- 00:00:05.279 the ADC Therapeutics 00:00:05.279 -- 00:00:08.639 Q2 twenty twenty six Earnings Conference Call. 00:00:08.880 -- 00:00:11.040 At this time, all lines are in listen 00:00:11.040 -- 00:00:13.724 only mode. Following the presentation, 00:00:13.725 -- 00:00:16.364 we will conduct a question and answer session. 00:00:16.685 -- 00:00:17.244 This 00:00:23.485 -- 00:00:27.724 call is being recorded on Thursday, 08/13/2026. 00:00:28.529 -- 00:00:30.210 I would now like to turn the conference 00:00:30.210 -- 00:00:33.250 over to Nicole Reilly, Head of Investor Relations 00:00:33.250 -- 00:00:35.010 and Corporate Communications. 00:00:35.489 -- 00:00:36.610 Please go ahead. 00:00:37.730 -- 00:00:40.370 Thank you, operator. Today, we issued a press 00:00:40.370 -- 00:00:43.015 release announcing our second quarter twenty twenty six 00:00:43.015 -- 00:00:45.175 financial results and business update. 00:00:45.495 -- 00:00:47.495 This release and the slides we will use 00:00:47.495 -- 00:00:50.375 in today's presentation are available on the Investors 00:00:50.375 -- 00:00:52.775 section of the ADC Therapeutics website. 00:00:53.700 -- 00:00:56.020 I'm joined on today's call by our Chief 00:00:56.020 -- 00:00:59.300 Executive Officer, Amit Malik, who will discuss our 00:00:59.300 -- 00:01:02.260 operational performance and recent business highlights, 00:01:02.500 -- 00:01:05.620 followed by our Chief Medical Officer, Mohammad Zaki, 00:01:05.825 -- 00:01:09.585 who will provide clinical and regulatory updates and 00:...